Champions Oncology
CSBR
10 hedge funds and large institutions have $26.2M invested in Champions Oncology in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
56.28% more ownership
Funds ownership: 0% → 56.28% (+56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Battery Partners IX
Boston,
Massachusetts
|
+$12.8M |
| 2 |
NEA Management Company
Timonium,
Maryland
|
+$10.2M |
| 3 |
PAR Capital Management
Boston,
Massachusetts
|
+$5.44M |
| 4 |
Perceptive Advisors
New York
|
+$2.43M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.11M |
Top Sellers
CSBR Hedge Fund Activity: Q3 2015 in Review
10 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q3 2015, worth a combined $26.2M.
Buyers outnumbered sellers: 10 funds opened new CSBR positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Battery Partners IX, opening a new position worth an estimated $12.8M.
- 10 institutional investors held Champions Oncology (CSBR) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $26.2M of Champions Oncology stock for Q3 2015.
- 10 funds opened new Champions Oncology positions in Q3 2015 and 0 closed out, a net change of +10 holders.
- The largest Champions Oncology buyer in Q3 2015 was Battery Partners IX, an estimated $12.8M added.
Based on aggregated 13F filings for Q3 2015.